Our study shows that the antitumor effect of genetic disruption of Cox-2 in tongue cancer prevention is bypassed by Zn depletion (Fig. 1), owing to activation of an alternative proneoplastic pathway that is not affected by COX-2 inhibition. The gene discussed is PTGS2; the disease is tongue cancer.